An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Practice

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This study is observational and seems to mainly track how finerenone is being prescribed and used in routine care in India — does that mean joining it wouldn't change my treatment, and how does that differ from a trial that's actually testing whether finerenone works?
2. 2Since this study is no longer actively enrolling, could I still be considered for it, or would my doctor recommend another way for me to access or learn about finerenone as a treatment option for my CKD and type 2 diabetes?
3. 3The study tracks whether patients stay on finerenone, change their dose, or stop it altogether — what would be the most likely reasons my doctor might adjust or discontinue finerenone if I were taking it, and what side effects should I watch for?
4. 4I see the study records both a 10 mg and a 20 mg starting dose of finerenone — how would my doctor decide which starting dose is right for me given my kidney function and diabetes, and what would trigger a dose change?
5. 5Compared to standard treatments I may already be on for CKD and type 2 diabetes, is finerenone something my doctor would consider adding now, or is there a preferred sequence of treatments I should go through first?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.